Objectives: In order to investigate alternate therapeutic option, this study was carried out to assess the in vitro antibacterial activity of gel extract of Aloe barbadensis against multiple antibiotic resistant Pseudomonas aeruginosa isolated from wound specimens.
INTRODUCTION
There is an increasing incidence of Pseudomonas aeruginosa in wound infections (Masaadeh and Jaran 2009 ) because an open wound provides a moist, warm and nutritious environment perfect for microbial colonization and proliferation (Benbow 2010) . P. aeruginosa is an opportunistic and highly resistant nosocomial pathogen. It can grow on a wide range of substrates and quickly respond to environmental alteration (Lambert 2002) . It can express virulence factors and surface proteins affecting wound healing.
The development of a wound infection following elective surgery or traumatic injury remains a major cause of morbidity in patients (Kim et al. 1999) .
Several studies have shown the emergence of multidrug resistant (MDR) isolates of P. aeruginosa associated with community acquired and nosocomial infections (Bhandari et al. 2015; Chaudhary et al. 2016; Fan et al. 2016) . Ali et al. (2015) (Malterud et al. 1993; Goudarzi et al. 2015) . Aloe barbadensis a medicinal plant, contains over 75 potentially active constituents including vitamins, enzymes, minerals, sugars, lignin, saponins, lupeol, salicylic acids, amino cinnamonic acid, phenols and sulfur (Surjushe et al. 2008 ). Many of these compounds are bactericidal, virucidal, fungicidal and antiinfl ammatory in nature (Hamman 2008) . Furthermore, the inhibitory action of extracts of A. barbasensis against many gram negative pathogens including P. aeruginosa has been recognized (Ibrahim et al. 2011; Renisheya et al. 2012; , Abakar et al. 2017) . However, its antibacterial activity against MDR P. aeruginosa has rarely been evaluated in Nepal.
Therefore, in this study, we tested in vitro inhibitory action of different organic extracts of locally available
A. barbadensis at different concentrations against MDR and non-MDR P. aeruginosa isolated from various wound specimens. 
MATERIALS AND METHODS

RESULTS
P. aeruginosa isolates from wound specimens and antibiotic resistance: Out of total 180 wound specimens, 38 (21.1%) of the specimens showed the occurrence of P. aeruginosa. The highest numbers of the P. aeruginosa isolates were recovered from burn wound infections (n = 7, 35.0%) while the lowest number from pus specimens (n = 9, 13.9%) ( Table 1) . Antibiotic susceptibility testing revealed that out of total 38 isolates of P. aeruginosa, 15 (39.0%) isolates were designated as MDR P. aeruginosa (Figure 2 ) while others were regarded as non-MDR. The highest number of MDR P. aeruginosa were isolated from burn wound specimens (n=6, 85.7%) followed by postoperative wound (n = 5, 62.5%). Compared to all non-MDR isolates, only two-third of MDR isolates (n = 5) of P. aeruginosa were sensitive towards Aloe extracts. A signifi cant statistical association (p < 0.05) was revealed between MDR status and the sensitivity towards A. barbadensis (Table 2) . 
DISCUSSION
In order to investigate an alternate therapeutic option, this study was carried out to assess the antibacterial activity of A. barbadensis against MDR P. aeruginosa isolated from wound specimens. Since P. aeruginosa is generally a part of wound infection etiology, the target pathogen was isolated from different types of wound specimens. In this study, P. aeruginosa was recovered from 21.1% as key etiological agent of wound infections. However, previous studies reported the prevalence of P. aeruginosa as 5.6% to 44.0% (Bhatt and Lakhey 2007; Bangera et al. 2015; Rai et al. 2017) . Considering variable prevalence of P. aeruginosa in different types of wound infections (Rajbahak et al. 2012; Bastola et al. 2017; Serra et al. 2015; Kshetry et al. 2015) , we selected burn wound swab, postoperative wound swab, chronic wound swab and pus specimens for this study where the burn wound specimens contributed maximum of P. aeruginosa isolates (35%).
Infections caused by P. aeruginosa are often severe and life threatening (Ahmed et al. 2008) and are diffi cult to treat because of its limited susceptibility to antimicrobial agents and the high frequency of the emergence of antibiotic resistance during therapy (Niederman, 2001; Paladino et al. 2002 ). Because we found high prevalence of MDR P. aeruginosa in wound infections (39.5%) which is higher than the study of Bangera et al. (2015) with resistance against the most of aminoglycoside, fl uoroquinolone and beta-lactams (Rajbahak et al. 2012) , we argue that there may be increasing trend of antibiotic resistance of P. aeruginosa causing wound infection. The high resistance of P. aeruginosa may be due to the intrinsic resistance like chromosomally encoded β-lactamase, biofi lm formation, energy dependent effl ux (Hancock 1997) and acquired resistance by mutational events leading to over-expression of endogenous β-lactamases or effl ux pumps, diminished expression of specifi c porins and target site modifi cations. Acquired resistance is also due to acquisition of resistance genes which mainly refers to transferable β-lactamases and aminoglycosidemodifying enzymes.
In order to assess the in vitro inhibitory activity of A. barbadensis, we analyzed if there is relation among concentration, types of extraction solvents and antibacterial activity of the A. barbadensis. We found that organic extracts with acetone, ethanol and DMSO extracts gave zone of inhibition in certain concentrations but not by aqueous extract. It may be due to partial solubility or insolubility of active compound in aqueous solution (non-polar nature and active compound). Broadly, the magnitude of inhibition was obtained in the pattern of acetone > DMSO > ethanol extracts (0.4 -0.8%). The results of this study corroborated with Ibrahim et al. (2011) that reported better antimicrobial activity of the acetone extract as compared to ethanol and aqueous extracts. In this study, the maximum zone of inhibition (21.3 ± 2.2 mm) by acetone extract at 0.8% concentration was found which was to be similar (21 mm by acetone extract) to the study of Abakar et al. (2017) for P. aeruginosa suggesting that acetone could be the best organic solvent for extraction. Various extracts showed different zone of inhibition which may be attributed to different solubility of various compounds found in Aloe barbadensis. More polar substances extract more of the compounds embedded within the plant cells (Karpagam and Devaraj 2011) . Our experiment showed that, the inhibitory action increases proportionately with the increment of concentration of the extracts corroborating with results of Renisheya et al. (2012) .
Among MDR isolates, two-thirds of the isolates were sensitive to aloe extract while all non-MDR isolates were found sensitive. The antibacterial activity of extract was found statistically associated with antibiotic resistance profi le of the organism (p<0.05). This indicates the multidrug resistant P. aeruginosa were less susceptible to aloe extract. Irrespective of the different wound specimens, the zone of inhibition was nearly similar for all isolates of P. aeruginosa. However, in a particular concentration of all extracts, there was no signifi cant difference in diameter of the zone of inhibition for MDR and non-MDR isolates (p > 0.05).
From this study it is clear that A. barbadensis demonstrates inhibitory activity against P. aeruginosa indicating its therapeutic potential. Lawrence et al. (2009) identifi ed the compounds with maximum antibacterial activity against P. aeruginosa as p-coumaric acid, pyrocatechol and cinnamic acid. Pyrocatechol denatures proteins and disrupts cell membranes (Cowan 1999) . Cinnamic acid inhibits glucose uptake and ATP production in the resting cells of bacteria (Kouassi and Shelef 1998) . Similarly, p-coumaric compound is reported to increase the lag phase of the microorganism (Baranowski et al. 1980) and is also able to inhibit the enzymatic activity of the microorganisms (Weir et al. 2004) . However, in this study the active compounds were not identifi ed. So it is recommended for further research that isolation of key bioactive compound of Nepalese variety of A. barbadensis would be useful asset in this regard.
CONCLUSION
Both the MDR and non-MDR isolates of P. aeruginosa recovered from wound specimens were inhibited in vitro by organic extracts of A. barbadensis. However, comparison study showed slightly higher frequency of non-MDR isolates was sensitive towards organic extracts of A. barbadensis. Acetone extract had comparatively better inhibitory activity and magnitude of in vitro inhibition was positively correlated with concentration of extracts. Though further confi rmation is necessary, in the light of the multiple antibiotic resistance problems, this study showed that A. barbadensis may be used as an alternate therapeutic option for the treatment of Pseudomonas caused infections more particularly wound infections. susceptibility testing; 26
